Neville Jonathan J, Macdonald Alexander, Fell John, Choudhry Muhammad, Haddad Munther
Department of Paediatric Surgery, Chelsea and Westminster Hospital, London, SW10 9NH, UK.
Department of Paediatric Gastroenterology, Chelsea and Westminster Hospital, London, UK.
Pediatr Surg Int. 2021 May;37(5):569-577. doi: 10.1007/s00383-020-04848-0. Epub 2021 Jan 25.
Childhood stricturing Crohn's disease (CD) has significant morbidity. Interventions including resection, stricturoplasty and endoscopic balloon dilatation (EBD) are often required. Optimal intervention modality and timing, and use of adjuvant medical therapies, remains unclear. We aim to review the therapies used in paediatric stricturing CD.
A systematic review in accordance with PRISMA was performed (PROSPERO: CRD42020164464). Demographics, stricture features, interventions and outcomes were extracted.
Fourteen studies were selected, including 177 patients (183 strictures). Strictures presented at 40.6 months (range 14-108) following CD diagnosis. Medical therapy was used in 142 patients for an average of 20.4 months (2-36), with a complete response in 11 (8%). Interventions were undertaken in 138 patients: 53 (38%) resections, 39 (28%) stricturoplasties, and 17 (12%) EBD. Complications occurred in 11% of resections, versus 15% stricturoplasties, versus 6% EBD (p = 0.223). At a median follow-up of 1.9 years (interquartile range 1.2-2.4) pooled stricture recurrence was 22%. Resection had 9% recurrence, versus 38% stricturoplasty, versus 47% EBD (p < 0.001).
Resection is associated with a low incidence of recurrence and complications. There remains a paucity of evidence regarding adjuvant medical therapy and the role of EBD. We propose a minimum reported dataset for interventions in paediatric stricturing CD.
儿童狭窄型克罗恩病(CD)具有较高的发病率。通常需要采取包括切除术、狭窄成形术和内镜球囊扩张术(EBD)在内的干预措施。最佳的干预方式和时机以及辅助药物治疗的使用仍不明确。我们旨在回顾用于小儿狭窄型CD的治疗方法。
按照PRISMA进行系统综述(国际前瞻性系统评价注册库:CRD42020164464)。提取人口统计学数据、狭窄特征、干预措施和结果。
共纳入14项研究,包括177例患者(183处狭窄)。狭窄出现在CD诊断后的40.6个月(范围14 - 108个月)。142例患者接受了药物治疗,平均治疗20.4个月(2 - 36个月),11例(8%)完全缓解。138例患者接受了干预:53例(38%)行切除术,39例(28%)行狭窄成形术,17例(12%)行EBD。切除术的并发症发生率为11%,狭窄成形术为15%,EBD为6%(p = 0.223)。中位随访1.9年(四分位间距1.2 - 2.4年),汇总的狭窄复发率为22%。切除术的复发率为9%,狭窄成形术为38%,EBD为47%(p < 0.001)。
切除术的复发率和并发症发生率较低。关于辅助药物治疗和EBD的作用,证据仍然不足。我们提出了小儿狭窄型CD干预措施的最低报告数据集。